Pregled bibliografske jedinice broj: 990504
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017 // Eurosurveillance, 23 (2018), 46; 1-17 doi:10.2807/1560-7917.ES.2018.23.46.1800516 (međunarodna recenzija, članak, stručni)
CROSBI ID: 990504 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial
resistance index in acute care hospitals and long-term care facilities: results from two European
point prevalence surveys, 2016 to 2017
Autori
Suetens, Carl ; Latour, Katrien ; Kärki, Tommi ; Ricchizzi, Enrico ; Kinross, Pete ; Moro, Maria ; Jans , Béatrice ; Hopkins, Susan ; Hansen, Sonja ; Lyytikäinen , Outi ; Reilly, Jacqui ; Deptula, Aleksander ; Zingg, Walter ; Plachouras, Diamantis ; Monnet, Dominique
Kolaboracija
The Healthcare-Associated Infections Prevalence Study Group
Izvornik
Eurosurveillance (1025-496X) 23
(2018), 46;
1-17
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
AMR ; HAI ; LTCF ; PPS ; antimicrobial resistance ; burden ; healthcare-associated infections ; hospitals ; long-term care facilities ; point prevalence survey
Sažetak
Oint prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included 310, 755 patients from 1, 209 acute care hospitals (ACH) in 28 countries and 117, 138 residents from 2, 221 long-term care facilities (LTCF) in 23 countries. After national validation, we estimated that 6.5% (cumulative 95% confidence interval (cCI): 5.4-7.8%) patients in ACH and 3.9% (95% cCI: 2.4-6.0%) residents in LTCF had at least one HAI (country-weighted prevalence). On any given day, 98, 166 patients (95% cCI: 81, 022-117, 484) in ACH and 129, 940 (95% cCI: 79, 570-197, 625) residents in LTCF had an HAI. HAI episodes per year were estimated at 8.9 million (95% cCI: 4.6-15.6 million), including 4.5 million (95% cCI: 2.6- 7.6 million) in ACH and 4.4 million (95% cCI: 2.0-8.0 million) in LTCF ; 3.8 million (95% cCI: 3.1-4.5 million) patients acquired an HAI each year in ACH. Antimicrobial resistance (AMR) to selected AMR markers was 31.6% in ACH and 28.0% in LTCF. Our study confirmed a high annual number of HAI in healthcare facilities in the EU/EEA and indicated that AMR in HAI in LTCF may have reached the same level as in ACH.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Napomena
Members of the Healthcare-Associated Infections Prevalence Study Group:
Zrinka Bošnjak (University of Zagreb School of Medicine, University Hospital Centre
Zagreb, Zagreb, Croatia); Ana Budimir (University of Zagreb School of Medicine, University
Hospital Centre Zagreb, Zagreb, Croatia)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE